ES2121404T3 - Procedimiento para la preparacion de trihidrato del (2r,3s)-3-terc-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4-acetoxi-2alfa-benzoiloxi-5beta,20-epoxi-1,7beta,10beta-trihidroxi-9-oxo-tax-11-en-13alfa-ilo. - Google Patents

Procedimiento para la preparacion de trihidrato del (2r,3s)-3-terc-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4-acetoxi-2alfa-benzoiloxi-5beta,20-epoxi-1,7beta,10beta-trihidroxi-9-oxo-tax-11-en-13alfa-ilo.

Info

Publication number
ES2121404T3
ES2121404T3 ES95925022T ES95925022T ES2121404T3 ES 2121404 T3 ES2121404 T3 ES 2121404T3 ES 95925022 T ES95925022 T ES 95925022T ES 95925022 T ES95925022 T ES 95925022T ES 2121404 T3 ES2121404 T3 ES 2121404T3
Authority
ES
Spain
Prior art keywords
ilo
tax
oxo
fenilpropionato
butoxicarbonilamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95925022T
Other languages
English (en)
Spanish (es)
Inventor
Jean-Rene Authelin
Jacques Doveze
Elie Fouque
Bernadette Mandard
Isabelle Taillepied
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9465183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2121404(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Application granted granted Critical
Publication of ES2121404T3 publication Critical patent/ES2121404T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
ES95925022T 1994-07-08 1995-07-07 Procedimiento para la preparacion de trihidrato del (2r,3s)-3-terc-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4-acetoxi-2alfa-benzoiloxi-5beta,20-epoxi-1,7beta,10beta-trihidroxi-9-oxo-tax-11-en-13alfa-ilo. Expired - Lifetime ES2121404T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9408479A FR2722191B1 (fr) 1994-07-08 1994-07-08 Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle

Publications (1)

Publication Number Publication Date
ES2121404T3 true ES2121404T3 (es) 1998-11-16

Family

ID=9465183

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95925022T Expired - Lifetime ES2121404T3 (es) 1994-07-08 1995-07-07 Procedimiento para la preparacion de trihidrato del (2r,3s)-3-terc-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4-acetoxi-2alfa-benzoiloxi-5beta,20-epoxi-1,7beta,10beta-trihidroxi-9-oxo-tax-11-en-13alfa-ilo.

Country Status (38)

Country Link
US (1) US6022985A (enExample)
EP (1) EP0770070B1 (enExample)
JP (1) JP3753155B2 (enExample)
KR (1) KR100391753B1 (enExample)
CN (1) CN1067996C (enExample)
AT (1) ATE171702T1 (enExample)
AU (1) AU706519B2 (enExample)
BR (1) BR9508789A (enExample)
CA (1) CA2193531C (enExample)
CO (1) CO4410189A1 (enExample)
CZ (1) CZ284695B6 (enExample)
DE (1) DE69505128T2 (enExample)
DK (1) DK0770070T3 (enExample)
DZ (1) DZ1905A1 (enExample)
ES (1) ES2121404T3 (enExample)
FI (1) FI119246B (enExample)
FR (1) FR2722191B1 (enExample)
GR (1) GR3027558T3 (enExample)
HU (1) HU220634B1 (enExample)
IL (1) IL114274A (enExample)
IN (1) IN183947B (enExample)
IS (1) IS2032B (enExample)
MA (1) MA23606A1 (enExample)
MX (1) MX9700173A (enExample)
MY (1) MY118481A (enExample)
NO (1) NO314500B1 (enExample)
NZ (1) NZ289455A (enExample)
PE (1) PE8697A1 (enExample)
PL (1) PL179876B1 (enExample)
RU (1) RU2126397C1 (enExample)
SI (1) SI0770070T1 (enExample)
SK (1) SK280520B6 (enExample)
TN (1) TNSN95071A1 (enExample)
TW (1) TW419473B (enExample)
UA (1) UA51624C2 (enExample)
UY (1) UY23991A1 (enExample)
WO (1) WO1996001815A1 (enExample)
ZA (1) ZA955646B (enExample)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU753781B2 (en) 1997-04-28 2002-10-31 Aventis Pharma S.A. Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
SE510650C2 (sv) * 1997-05-30 1999-06-14 Astra Ab Ny förening
FR2794771B1 (fr) 1999-06-11 2001-08-10 Aventis Pharma Sa Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
US6853921B2 (en) 1999-07-20 2005-02-08 Halliburton Energy Services, Inc. System and method for real time reservoir management
US6266619B1 (en) * 1999-07-20 2001-07-24 Halliburton Energy Services, Inc. System and method for real time reservoir management
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
US6891050B2 (en) * 2001-08-10 2005-05-10 Dabur India Limited Process for the preparation of taxanes such as paclitaxel, docetaxel and structurally similar analogs
US6881852B2 (en) * 2002-02-05 2005-04-19 Dabur India Limited Process of purification of paclitaxel and docetaxel
US7247738B2 (en) * 2002-05-07 2007-07-24 Dabur India Limited Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl) ethoxycarbonyl]-5-oxazolidine carboxylic acids
US6900342B2 (en) * 2002-05-10 2005-05-31 Dabur India Limited Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof
US6838569B2 (en) * 2002-12-16 2005-01-04 Dabur India Limited Process for preparation of paclitaxel trihydrate and docetaxel trihydrate
US7584165B2 (en) * 2003-01-30 2009-09-01 Landmark Graphics Corporation Support apparatus, method and system for real time operations and maintenance
US8703982B2 (en) 2003-03-17 2014-04-22 Phyton Holdings Llc Purification of taxanes
CN1268619C (zh) * 2003-05-08 2006-08-09 上海迪赛诺化学制药有限公司 多烯紫杉醇三水化合物的制备方法
FR2859996B1 (fr) * 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
EP1947094A3 (en) 2003-12-12 2009-02-18 Quiral Quimica Do Brasil Process for the preparation of taxane derivatives
US7142986B2 (en) * 2005-02-01 2006-11-28 Smith International, Inc. System for optimizing drilling in real time
CN100420681C (zh) * 2005-04-29 2008-09-24 上海奥锐特国际贸易有限公司 多烯紫杉醇三水物的制备方法
CN101291658B (zh) 2005-08-31 2014-04-16 阿布拉科斯生物科学有限公司 用于制备稳定性增加的水难溶性药物的组合物和方法
US7771751B2 (en) 2005-08-31 2010-08-10 Abraxis Bioscience, Llc Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents
WO2007044950A2 (en) * 2005-10-12 2007-04-19 Sicor, Inc. Crystalline forms of docetaxel and processes for their preparation
KR100995390B1 (ko) 2006-01-02 2010-11-19 주식회사 삼양제넥스 무정형, 무수결정형 또는 수화 결정형 도세탁셀의 제조방법
WO2007084611A2 (en) * 2006-01-20 2007-07-26 Landmark Graphics Corporation Dynamic production system management
KR20080100264A (ko) * 2006-03-21 2008-11-14 닥터 레디스 레보러터리즈 리미티드 도세탁셀의 다형체와 그 제조방법
EP2330101A1 (en) * 2006-10-20 2011-06-08 Scinopharm Singapore Pte, Ltd. Process for making crystalline docetaxel
KR100868116B1 (ko) * 2007-04-09 2008-11-10 한미약품 주식회사 도세탁셀·모노프로필렌글라이콜 내포화합물 및 이의제조방법
KR100878455B1 (ko) 2007-04-10 2009-01-13 한미약품 주식회사 안정한 무수결정형 도세탁셀 및 이의 제조방법
WO2009006590A2 (en) * 2007-07-04 2009-01-08 Dr. Reddy's Laboratories Ltd. Docetaxel process and polymorphs
EP2080763A1 (en) * 2008-01-18 2009-07-22 INDENA S.p.A. Crystalline form I of ortataxel
EP2080764B1 (en) 2008-01-18 2012-08-22 INDENA S.p.A. Solid forms of ortataxel
PL388144A1 (pl) 2009-05-29 2010-12-06 Przedsiębiorstwo Produkcyjno-Wdrożeniowe Ifotam Spółka Z Ograniczoną Odpowiedzialnością Solwaty (2R,3S)-3-tert-butoksykarbonylamino-2-hydroksy-3-fenylopropionianu 4-acetoksy-2α-benzoiloksy -5β,20-epoksy-1,7β,10β-trihydroksy-9-okso-taks-11-en-13α-ylu, sposób ich otrzymywania i zastosowanie
US8686165B2 (en) * 2009-11-04 2014-04-01 Emcure Pharmaceuticals Limited Process for preparation of taxane derivatives
JP5824511B2 (ja) 2010-05-03 2015-11-25 テイコク ファーマ ユーエスエー インコーポレーテッド 非水タキサンプロエマルジョン配合物ならびにそれを調製および使用する方法
WO2012160568A1 (en) * 2011-05-23 2012-11-29 Shilpa Medicare Limited Process for preparing docetaxel trihydrate polymorph
ES2704632T3 (es) 2011-09-08 2019-03-19 Univ New York Virus de herpes simplex oncolítico y sus usos terapéuticos
US9745631B2 (en) 2011-12-20 2017-08-29 Dana-Farber Cancer Institute, Inc. Methods for diagnosing and treating oncogenic kras-associated cancer
EP2833905B1 (en) 2012-04-04 2018-05-02 Halozyme, Inc. Combination therapy with hyaluronidase and a tumor-targeted taxane
AU2013266243A1 (en) 2012-05-24 2014-12-18 Beth Israel Deaconess Medical Center, Inc. Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer
WO2014014518A1 (en) 2012-07-18 2014-01-23 Dana-Farber Cancer Institute, Inc. Methods for treating, preventing and predicting risk of developing breast cancer
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
US10238723B2 (en) 2013-03-14 2019-03-26 Icahn School Of Medicine At Mount Sinai Autologous tumor lysate-loaded dendritic cell vaccine for treatment of liver cancer
WO2015050844A1 (en) 2013-10-01 2015-04-09 Dana-Farber Cancer Institute, Inc. Methods of treating cancer with atovaquone-related compounds
WO2015149006A2 (en) 2014-03-27 2015-10-01 Dana-Farber Cancer Institute, Inc. Compositions and methods for modulating ncoa4-mediated autophagic targeting of ferritin
MA39818A (fr) 2014-03-30 2017-02-08 Benevir Biopharm Inc Virus oncolytiques « armés » comprenant un inhibiteur de tap exogène et leurs utilisations thérapeutiques
EP3307330B1 (en) 2015-06-15 2021-03-10 New York University Method of treatment using oncolytic viruses
WO2019222435A1 (en) 2018-05-16 2019-11-21 Halozyme, Inc. Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US5229526A (en) * 1991-09-23 1993-07-20 Florida State University Metal alkoxides

Also Published As

Publication number Publication date
IL114274A0 (en) 1995-10-31
FI119246B (fi) 2008-09-15
BR9508789A (pt) 1997-10-21
UA51624C2 (uk) 2002-12-16
DK0770070T3 (da) 1999-03-01
SK280520B6 (sk) 2000-03-13
NO970007D0 (no) 1997-01-02
PL179876B1 (pl) 2000-11-30
DE69505128T2 (de) 1999-04-01
TNSN95071A1 (fr) 1996-02-06
DZ1905A1 (fr) 2002-02-17
MY118481A (en) 2004-11-30
KR100391753B1 (ko) 2004-02-11
IL114274A (en) 1999-04-11
UY23991A1 (es) 1995-09-20
CO4410189A1 (es) 1997-01-09
FR2722191A1 (fr) 1996-01-12
HU9700041D0 (en) 1997-02-28
CA2193531C (fr) 2006-12-05
CN1151741A (zh) 1997-06-11
FI970069L (fi) 1997-01-07
CZ3597A3 (en) 1997-04-16
FI970069A0 (fi) 1997-01-07
MX9700173A (es) 1997-04-30
WO1996001815A1 (fr) 1996-01-25
CN1067996C (zh) 2001-07-04
JPH10502627A (ja) 1998-03-10
KR970704721A (ko) 1997-09-06
ATE171702T1 (de) 1998-10-15
IN183947B (enExample) 2000-05-20
AU2930595A (en) 1996-02-09
JP3753155B2 (ja) 2006-03-08
AU706519B2 (en) 1999-06-17
GR3027558T3 (en) 1998-11-30
PE8697A1 (es) 1997-03-26
EP0770070A1 (fr) 1997-05-02
ZA955646B (en) 1996-02-21
RU2126397C1 (ru) 1999-02-20
EP0770070B1 (fr) 1998-09-30
CA2193531A1 (fr) 1996-01-25
IS2032B (is) 2005-08-15
NO970007L (no) 1997-01-02
PL318195A1 (en) 1997-05-26
US6022985A (en) 2000-02-08
MA23606A1 (fr) 1996-04-01
NO314500B1 (no) 2003-03-31
TW419473B (en) 2001-01-21
HU220634B1 (hu) 2002-03-28
SK697A3 (en) 1997-06-04
NZ289455A (en) 1997-12-19
HUT76833A (en) 1997-11-28
FR2722191B1 (fr) 1996-08-23
CZ284695B6 (cs) 1999-02-17
SI0770070T1 (en) 1998-12-31
IS4411A (is) 1997-01-07
DE69505128D1 (de) 1998-11-05

Similar Documents

Publication Publication Date Title
ES2037055T3 (es) Procedimiento para la obtencion de 5-nitrobenzo(de)isoquinolin-1,3-dionas.
FI970069L (fi) Menetelmä (2R-3S)-(4-asetoksi-2alfa-bentsoyylioksi-5beta,20-epoksi-1,7beta,10beta-trihydroksi-9-oksotaks-11-en-13alfa-yyli)-3-tert-butoksikarbonyyliamino-3-fenyyli-2-hydroksipropionaatin trihydraatin valmistamiseksi
DE58905458D1 (de) Endoskop, insbesondere Arthroskop.
ID26043A (id) Turunan-turunan 1,3,5-triazina tertrisubstitusi untuk pengobatan infeksi-infeksi hiv
ITFI910071U1 (it) Piastra per osso per la porzione distale dell'omero.
HRP20000494B1 (en) Pharmaceutically active morpholinol
DZ3079A1 (fr) Procédé pour la préparation de 4-carboxy-amino-2-substitué-1,2,3,4 tétrahydroquinolé.
BR0002073A (pt) Processo para a preparação de um composto quiral
ES2139332T3 (es) Procedimiento para la preparacion del trihidrato del (2r,3s)-3-benzoilamino-2-hidroxi-3-fenilpropionato de 4,10-diacetoxi-2alfa-benzoiloxi-5beta,20-epoxi-1,7beta-dihidroxi-9-oxo-tax-11-en-13alfa-ilo.
FI885346L (fi) Ergolinderivat, som foerhindrar parkinsons sjukdom.
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
CY1116418T1 (el) Διεργασια για την παραγωγη r-(+)-6-καρβοξαμιδο-3-ν-μεθυλαμινο-1,2,3,4-τετραϋδροκαρβαζολιου
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
DE69005915D1 (de) Desinfektionssystem, insbesondere für zahnärztliche Handstücke.
ATE110261T1 (de) Feste orale applikationsformen, die als wirkstoff ifosfamid enthalten.
ES519108A0 (es) Procedimiento para la produccion de una 3,3-dialquil-o 3,3-dialquileno-indolina.
AR004380A1 (es) Dihidrato del (2r-3s)-3-ter-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4,10 beta-diacetoxi-2 alfa, -benzoiloxi-5beta, 20-epoxi -1-hidroxi-9-oxo-19-norciclopropa [g]tax-11-eno-13alfa-ilo y su procedimiento de preparacion.
IT9022507A0 (it) Procedimento per la preparazione di n-(26ammino63,5-dibromo-benzil)-trans-4-amminocicloesanolo3.
OA09301A (fr) "Nouvelle forme galénique orale améliorant la biodisponibilité".
IT1320082B1 (it) Procedimento per la realizzazione di reggiseni, nonche' reggisenocosi' ottenuto.
ES2039436T3 (es) Un procedimiento para preparar una composicion farmaceutica.
DE69207646D1 (de) Verbesserungen an Spiralbohrern für die Knochenchirurgie, insbesondere für die Zahnchirurgie
ES2016651B3 (es) Proceso mejorado para la preparacion de n,n'tetratiodimorfolinas.
BG106428A (en) Pharmaceutical compositions for treating psoriasis
ES1023392Y (es) Porta hilo, dental para hilo desechable.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 770070

Country of ref document: ES